H.C. Wainwright Reiterates Buy Rating on Sana Biotechnology (SANA)

March 16, 2026 6:50 AM

H.C. Wainwright analyst Emily Bodnar reiterated a Buy rating and $7.00 price target on Sana Biotechnology (NASDAQ: SANA).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found